
- Volume 0 0
Drugs' Outcomes Are Comparable for African Americans
A study of 20,000 African Americans revealed thatno hypertension medication wins over another at loweringthe risk of death and pressure-related problems,if the patient's goal blood pressure is achieved. Usingdatabases to find trials that assessed the effectivenessof various types of blood pressure medicationsin African Americans, the researchers found thatbeta-blockers and angiotensin-converting enzyme(ACE) inhibitors were more effective than a placeboin reducing upper and lower numbers.
The researchers found, in contrast, that all otherclasses of blood pressure drugs were no more effectivethan placebo at lowering blood pressure. Yet, theonly drug class that, without fail, was better than aplacebo in all of these patients was calcium channelblockers. In the Annals of Internal Medicine (October19, 2004), the researchers said that, as long as thegoal blood pressure was reached, the type of drugused did not affect outcomes such as stroke anddeath because of cardiovascular disorders. Thestudy, however, showed some evidence that the riskof diabetes may have increased with diuretics, andcardiovascular events may have increased with ACEinhibitors, compared with other blood pressure drugs.
Articles in this issue
about 21 years ago
Treatment of Patients with Atrial Fibrillationabout 21 years ago
Understanding and Managing Polypharmacy in the Elderlyabout 21 years ago
Counterfeit Drugs: A Real Cause for Alarmabout 21 years ago
New Treatments on the Way for Diabetes-Part 1about 21 years ago
Effective Counseling for Patients with Hypertensionabout 21 years ago
Preventing and Managing Thrombosis with Anticoagulantsabout 21 years ago
RxPRODUCT NEWS: PROFILE: Cardizem LA (diltiazem hydrochloride)about 21 years ago
Staying Well with Herbs and Vitaminsabout 21 years ago
Health Professional Imposters-Part 1Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.



















































































































































































































